\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.1.1}{Spatial patterning in biological systems}{chapter.1}% 2
\BOOKMARK [1][-]{section.1.2}{Cell polarity}{chapter.1}% 3
\BOOKMARK [2][-]{subsection.1.2.1}{The Min system}{section.1.2}% 4
\BOOKMARK [2][-]{subsection.1.2.2}{CDC-42 polarity in yeast}{section.1.2}% 5
\BOOKMARK [2][-]{subsection.1.2.3}{PAR polarity}{section.1.2}% 6
\BOOKMARK [1][-]{section.1.3}{Maintenance of cell polarity by bistable reaction-diffusion systems}{chapter.1}% 7
\BOOKMARK [2][-]{subsection.1.3.1}{Bistable reaction kinetics}{section.1.3}% 8
\BOOKMARK [2][-]{subsection.1.3.2}{Single species polarity models}{section.1.3}% 9
\BOOKMARK [2][-]{subsection.1.3.3}{The mutual antagonism model}{section.1.3}% 10
\BOOKMARK [1][-]{section.1.4}{A molecular basis for ultrasensitivity}{chapter.1}% 11
\BOOKMARK [2][-]{subsection.1.4.1}{Ultrasensitivity in protein phosphorylation reactions}{section.1.4}% 12
\BOOKMARK [2][-]{subsection.1.4.2}{Ultrasensitivity through cooperative membrane binding}{section.1.4}% 13
\BOOKMARK [1][-]{section.1.5}{PAR polarity in C elegans zygotes}{chapter.1}% 14
\BOOKMARK [2][-]{subsection.1.5.1}{Mechanisms of PAR cortical association}{section.1.5}% 15
\BOOKMARK [2][-]{subsection.1.5.2}{Maintenance of polarity by mutual antagonism}{section.1.5}% 16
\BOOKMARK [2][-]{subsection.1.5.3}{Establishment of polarity}{section.1.5}% 17
\BOOKMARK [2][-]{subsection.1.5.4}{Downstream of the PAR proteins}{section.1.5}% 18
\BOOKMARK [2][-]{subsection.1.5.5}{Resistance and substrate competition}{section.1.5}% 19
\BOOKMARK [2][-]{subsection.1.5.6}{Discussion}{section.1.5}% 20
\BOOKMARK [1][-]{section.1.6}{PAR-2: roles and mechanisms of action}{chapter.1}% 21
\BOOKMARK [2][-]{subsection.1.6.1}{Main functional roles of PAR-2}{section.1.6}% 22
\BOOKMARK [2][-]{subsection.1.6.2}{Evidence and proposed roles for oligomerisation}{section.1.6}% 23
\BOOKMARK [2][-]{subsection.1.6.3}{Roles for the RING domain}{section.1.6}% 24
\BOOKMARK [2][-]{subsection.1.6.4}{Discussion}{section.1.6}% 25
\BOOKMARK [0][-]{chapter.2}{A pipeline for quantification of membrane and cytoplasmic protein concentrations}{}% 26
\BOOKMARK [1][-]{section.2.1}{Introduction}{chapter.2}% 27
\BOOKMARK [1][-]{section.2.2}{Autofluorescence correction}{chapter.2}% 28
\BOOKMARK [2][-]{subsection.2.2.1}{Autofluorescence in C. elegans}{section.2.2}% 29
\BOOKMARK [2][-]{subsection.2.2.2}{SAIBR: a simplified method for autofluorescence correction based on dual emission imaging}{section.2.2}% 30
\BOOKMARK [2][-]{subsection.2.2.3}{Assessing SAIBR performance on images of PAR proteins}{section.2.2}% 31
\BOOKMARK [2][-]{subsection.2.2.4}{Extending SAIBR to dual-labelled C. elegans embryos}{section.2.2}% 32
\BOOKMARK [2][-]{subsection.2.2.5}{Discussion}{section.2.2}% 33
\BOOKMARK [1][-]{section.2.3}{Extracting membrane and cytoplasmic signal components}{chapter.2}% 34
\BOOKMARK [2][-]{subsection.2.3.1}{An overview of existing methods}{section.2.3}% 35
\BOOKMARK [2][-]{subsection.2.3.2}{Accounting for out-of-focus scatter}{section.2.3}% 36
\BOOKMARK [2][-]{subsection.2.3.3}{A gradient descent protocol for image quantification}{section.2.3}% 37
\BOOKMARK [2][-]{subsection.2.3.4}{Segmentation}{section.2.3}% 38
\BOOKMARK [2][-]{subsection.2.3.5}{Benchmarking the method}{section.2.3}% 39
\BOOKMARK [2][-]{subsection.2.3.6}{Calibrating concentration units}{section.2.3}% 40
\BOOKMARK [2][-]{subsection.2.3.7}{Discussion}{section.2.3}% 41
\BOOKMARK [0][-]{chapter.3}{Uncovering a PAR-2 positive feedback circuit}{}% 42
\BOOKMARK [1][-]{section.3.1}{Introduction}{chapter.3}% 43
\BOOKMARK [2][-]{subsection.3.1.1}{The PAR-2 polarity pathway}{section.3.1}% 44
\BOOKMARK [2][-]{subsection.3.1.2}{Self-recruitment}{section.3.1}% 45
\BOOKMARK [2][-]{subsection.3.1.3}{RING domain}{section.3.1}% 46
\BOOKMARK [2][-]{subsection.3.1.4}{Substrate-kinase interaction}{section.3.1}% 47
\BOOKMARK [2][-]{subsection.3.1.5}{Outlook}{section.3.1}% 48
\BOOKMARK [1][-]{section.3.2}{Quantitative characterisation of PAR-2 mutant alleles}{chapter.3}% 49
\BOOKMARK [1][-]{section.3.3}{RING domain promotes positive feedback to achieve optimal membrane affinity}{chapter.3}% 50
\BOOKMARK [1][-]{section.3.4}{Discussion}{chapter.3}% 51
\BOOKMARK [0][-]{chapter.4}{Determining mechanisms of PAR-2 RING domain action}{}% 52
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 53
\BOOKMARK [1][-]{section.4.2}{Exploring a role for ubiquitination}{chapter.4}% 54
\BOOKMARK [2][-]{subsection.4.2.1}{PAR-2 does not show activity in in vitro ubiquitination assays}{section.4.2}% 55
\BOOKMARK [2][-]{subsection.4.2.2}{Targeted mutation to putative linchpin site has no phenotype}{section.4.2}% 56
\BOOKMARK [2][-]{subsection.4.2.3}{Discussion}{section.4.2}% 57
\BOOKMARK [1][-]{section.4.3}{Exploring a role for dimerisation}{chapter.4}% 58
\BOOKMARK [2][-]{subsection.4.3.1}{PAR-2 RING domain sequence bears hallmarks of dimeric RINGs}{section.4.3}% 59
\BOOKMARK [2][-]{subsection.4.3.2}{The PAR-2 RING domain displays concentration-dependent dimerisation in vitro}{section.4.3}% 60
\BOOKMARK [2][-]{subsection.4.3.3}{Dimerisation is mediated by 4-helix bundle with hydrophobic core}{section.4.3}% 61
\BOOKMARK [2][-]{subsection.4.3.4}{Cytoplasmic PAR-2 does not self-associate in vivo}{section.4.3}% 62
\BOOKMARK [2][-]{subsection.4.3.5}{Membrane-enriched PAR-2 self-associates in vivo}{section.4.3}% 63
\BOOKMARK [2][-]{subsection.4.3.6}{Mutation to dimerisation interface weakens membrane association in vivo}{section.4.3}% 64
\BOOKMARK [2][-]{subsection.4.3.7}{Discussion}{section.4.3}% 65
\BOOKMARK [0][-]{chapter.5}{Modelling the interplay between dimerisation and membrane association}{}% 66
\BOOKMARK [1][-]{section.5.1}{Introduction}{chapter.5}% 67
\BOOKMARK [1][-]{section.5.2}{Modelling chemical equilibria}{chapter.5}% 68
\BOOKMARK [1][-]{section.5.3}{A thermodynamic model of dimerisation and membrane association}{chapter.5}% 69
\BOOKMARK [2][-]{subsection.5.3.1}{Thermodynamic description of membrane association}{section.5.3}% 70
\BOOKMARK [2][-]{subsection.5.3.2}{Thermodynamic description of dimerisation}{section.5.3}% 71
\BOOKMARK [2][-]{subsection.5.3.3}{Combining membrane association and dimerisation}{section.5.3}% 72
\BOOKMARK [2][-]{subsection.5.3.4}{Intermediate dimerisation can drive nonlinear membrane association}{section.5.3}% 73
\BOOKMARK [1][-]{section.5.4}{Quantitative assessment of PAR-2 membrane association behaviour}{chapter.5}% 74
\BOOKMARK [1][-]{section.5.5}{Discussion}{chapter.5}% 75
\BOOKMARK [0][-]{chapter.6}{Assessing the impacts of PAR-2 dimerisation in polarity models}{}% 76
\BOOKMARK [1][-]{section.6.1}{Introduction}{chapter.6}% 77
\BOOKMARK [1][-]{section.6.2}{Describing membrane binding dynamics with transition state theory}{chapter.6}% 78
\BOOKMARK [1][-]{section.6.3}{Exploring the effects of membrane lifetime in the mutual antagonism model}{chapter.6}% 79
\BOOKMARK [2][-]{subsection.6.3.1}{Conditions for polarisation}{section.6.3}% 80
\BOOKMARK [2][-]{subsection.6.3.2}{Low off rates strengthen pattern asymmetries}{section.6.3}% 81
\BOOKMARK [2][-]{subsection.6.3.3}{Low off rates enhance pattern stability}{section.6.3}% 82
\BOOKMARK [2][-]{subsection.6.3.4}{Conclusions}{section.6.3}% 83
\BOOKMARK [1][-]{section.6.4}{Exploring the effects of dimerisation-driven feedback in polarity models}{chapter.6}% 84
\BOOKMARK [2][-]{subsection.6.4.1}{Separating the effects of dimerisation on membrane affinity and feedback}{section.6.4}% 85
\BOOKMARK [2][-]{subsection.6.4.2}{Modelling aPAR to pPAR antagonism}{section.6.4}% 86
\BOOKMARK [2][-]{subsection.6.4.3}{Dimerisation can generate nonlinear antagonism}{section.6.4}% 87
\BOOKMARK [2][-]{subsection.6.4.4}{Dimerisation-driven nonlinearities are sufficient for polarity in self-organising models}{section.6.4}% 88
\BOOKMARK [1][-]{section.6.5}{Discussion}{chapter.6}% 89
\BOOKMARK [0][-]{chapter.7}{Experimental manipulation of PAR-2 dimerisation}{}% 90
\BOOKMARK [1][-]{section.7.1}{Introduction}{chapter.7}% 91
\BOOKMARK [1][-]{section.7.2}{Forced constitutive dimerisation of PAR-2 shifts localisation pattern}{chapter.7}% 92
\BOOKMARK [1][-]{section.7.3}{Incorporating internal membranes into the thermodynamic model}{chapter.7}% 93
\BOOKMARK [1][-]{section.7.4}{Modelling kinetics outside of equilibrium}{chapter.7}% 94
\BOOKMARK [1][-]{section.7.5}{aPAR disruption partially restores expected equilibrium localisation pattern}{chapter.7}% 95
\BOOKMARK [1][-]{section.7.6}{Discussion}{chapter.7}% 96
\BOOKMARK [0][-]{chapter.8}{Discussion}{}% 97
\BOOKMARK [0][-]{chapter.9}{Materials and methods}{}% 98
\BOOKMARK [1][-]{section.9.1}{C. elegans methods}{chapter.9}% 99
\BOOKMARK [2][-]{subsection.9.1.1}{Worm maintenance}{section.9.1}% 100
\BOOKMARK [2][-]{subsection.9.1.2}{Worm strains}{section.9.1}% 101
\BOOKMARK [2][-]{subsection.9.1.3}{RNA interference}{section.9.1}% 102
\BOOKMARK [2][-]{subsection.9.1.4}{Brood size assays}{section.9.1}% 103
\BOOKMARK [1][-]{section.9.2}{CRISPR}{chapter.9}% 104
\BOOKMARK [2][-]{subsection.9.2.1}{Overview of CRISPR strategies}{section.9.2}% 105
\BOOKMARK [2][-]{subsection.9.2.2}{Testing a method for insertions at the glh-1 site}{section.9.2}% 106
\BOOKMARK [2][-]{subsection.9.2.3}{PAR-2 point mutations}{section.9.2}% 107
\BOOKMARK [2][-]{subsection.9.2.4}{Mitochondrial GBP}{section.9.2}% 108
\BOOKMARK [2][-]{subsection.9.2.5}{Membrane tethered PAR-2 RING fragment}{section.9.2}% 109
\BOOKMARK [2][-]{subsection.9.2.6}{RING domain fragment}{section.9.2}% 110
\BOOKMARK [1][-]{section.9.3}{Microscopy}{chapter.9}% 111
\BOOKMARK [1][-]{section.9.4}{In vitro methods}{chapter.9}% 112
\BOOKMARK [2][-]{subsection.9.4.1}{Full-length PAR-2 purification}{section.9.4}% 113
\BOOKMARK [2][-]{subsection.9.4.2}{Ubiquitination assays}{section.9.4}% 114
\BOOKMARK [2][-]{subsection.9.4.3}{PAR-2 RING domain fragment purification}{section.9.4}% 115
\BOOKMARK [2][-]{subsection.9.4.4}{SEC-MALS}{section.9.4}% 116
\BOOKMARK [1][-]{section.9.5}{Modelling methods}{chapter.9}% 117
\BOOKMARK [2][-]{subsection.9.5.1}{Simulations}{section.9.5}% 118
\BOOKMARK [2][-]{subsection.9.5.2}{Creating qualitative parameter space maps}{section.9.5}% 119
\BOOKMARK [0][-]{chapter*.97}{Appendix 1: Modelling the PAR-2/PKC-3 substrate/kinase interaction}{}% 120
\BOOKMARK [0][-]{chapter*.103}{Appendix 2: Analysis of PAR-2 diffusion by single particle tracking}{}% 121
\BOOKMARK [0][-]{chapter*.104}{Abbreviations}{}% 122
\BOOKMARK [0][-]{chapter*.104}{Bibliography}{}% 123
